naloxone hydrochloride

Generic: naloxone hydrochloride

Labeler: hf acquisition co. llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name naloxone hydrochloride
Generic Name naloxone hydrochloride
Labeler hf acquisition co. llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Active Ingredients

naloxone hydrochloride .4 mg/mL

Manufacturer
HF Acquisition Co. LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1238
Product ID 51662-1238_ef6a784b-3d10-da51-e053-2a95a90ad05d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA070172
Listing Expiration 2026-12-31
Marketing Start 2018-09-03

Pharmacologic Class

Classes
opioid antagonist [epc] opioid antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621238
Hyphenated Format 51662-1238

Supplemental Identifiers

RxCUI
1191234
UNII
F850569PQR

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name naloxone hydrochloride (source: ndc)
Generic Name naloxone hydrochloride (source: ndc)
Application Number ANDA070172 (source: ndc)
Routes
INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • .4 mg/mL
source: ndc
Packaging
  • 1 mL in 1 CARTRIDGE (51662-1238-1)
source: ndc

Packages (1)

Ingredients (1)

naloxone hydrochloride (.4 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "ef6a784b-3d10-da51-e053-2a95a90ad05d", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1191234"], "spl_set_id": ["74fcd243-94b3-ec77-e053-2991aa0a229c"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 CARTRIDGE (51662-1238-1)", "package_ndc": "51662-1238-1", "marketing_start_date": "20180903"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1238_ef6a784b-3d10-da51-e053-2a95a90ad05d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1238", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co. LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070172", "marketing_category": "ANDA", "marketing_start_date": "20180903", "listing_expiration_date": "20261231"}